alovudine has been researched along with Adverse Drug Event in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM | 1 |
Agool, A; Been, LB; Burlage, FR; Cobben, DC; Dierckx, RA; Elsinga, PH; Glaudemans, AW; Holter, JL; Slart, RH; Thorp, KK; Vellenga, E | 1 |
1 trial(s) available for alovudine and Adverse Drug Event
Article | Year |
---|---|
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Female; Glioma; Humans; Male; Middle Aged; National Cancer Institute (U.S.); Neoplasm Recurrence, Local; Positron-Emission Tomography; Potassium; United States | 2008 |
1 other study(ies) available for alovudine and Adverse Drug Event
Article | Year |
---|---|
Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
Topics: Adult; Aged; Bone Marrow; Dideoxynucleosides; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Humans; Laryngeal Neoplasms; Male; Neoplasms, Germ Cell and Embryonal; Positron-Emission Tomography; Radiotherapy; Retrospective Studies; Testicular Neoplasms | 2011 |